| Acetaminophen (Ofirmev IV / Tylenol PO) | 650–1000 mg q6h (max 4g/day; 2g if liver disease) | Non-opioid baseline -schedule for ALL ICU patients | Reduces opioid need 20–30%. Very safe. Should be scheduled, not PRN. |
| Ketamine (Ketalar) -sub-dissociative | 0.1–0.3 mg/kg/hr IV | Opioid-sparing. Neuropathic pain. Bronchospasm. Hemodynamically unstable. | NMDA antagonist -synergistic with opioids. Reduces opioid use 30–50%. Bronchodilator. |
| Ketorolac (Toradol) | 15–30 mg IV q6h (max 5 days) | Short-term non-opioid. Post-op. Renal colic. | Avoid: renal failure, GI bleed, platelet dysfunction, elderly. Max 5 days. |
| Gabapentin (Neurontin) | 100–300 mg PO TID (renal dose!) | Neuropathic pain adjunct | Renally cleared -#1 cause of iatrogenic AMS in CKD patients. Always renal dose. |
| Lidocaine patch (Lidoderm 5%) | 1–3 patches, 12h on / 12h off | Localized pain (rib fractures, post-herpetic, incision site) | No systemic side effects. Underutilized opioid-sparing option. |
| Pregabalin (Lyrica) | 25–150 mg PO BID (renal dose!) | Neuropathic pain. Alternative to gabapentin. | Also renally cleared. Dose-adjust in CKD. Fewer drug interactions than gabapentin. |